[go: up one dir, main page]

AU2056397A - Hydroxyazepanes as inhibitors of glycosidase and hiv protease - Google Patents

Hydroxyazepanes as inhibitors of glycosidase and hiv protease

Info

Publication number
AU2056397A
AU2056397A AU20563/97A AU2056397A AU2056397A AU 2056397 A AU2056397 A AU 2056397A AU 20563/97 A AU20563/97 A AU 20563/97A AU 2056397 A AU2056397 A AU 2056397A AU 2056397 A AU2056397 A AU 2056397A
Authority
AU
Australia
Prior art keywords
hydroxyazepanes
glycosidase
inhibitors
hiv protease
hiv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU20563/97A
Inventor
Francisco Moris-Varas
Chi-Huey Wong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Research Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Research Institute filed Critical Scripps Research Institute
Publication of AU2056397A publication Critical patent/AU2056397A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/001Amines; Imines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10Nitrogen as only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AU20563/97A 1997-02-21 1997-02-21 Hydroxyazepanes as inhibitors of glycosidase and hiv protease Abandoned AU2056397A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1997/002927 WO1998037218A1 (en) 1997-02-21 1997-02-21 Hydroxyazepanes as inhibitors of glycosidase and hiv protease

Publications (1)

Publication Number Publication Date
AU2056397A true AU2056397A (en) 1998-09-09

Family

ID=22260424

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20563/97A Abandoned AU2056397A (en) 1997-02-21 1997-02-21 Hydroxyazepanes as inhibitors of glycosidase and hiv protease

Country Status (4)

Country Link
JP (1) JP2001515471A (en)
AU (1) AU2056397A (en)
CA (1) CA2282254C (en)
WO (1) WO1998037218A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6860891B2 (en) 2001-09-28 2005-03-01 Ethicen, Inc. Arrangement and method for vascular anastomosis
CN102993095B (en) * 2012-11-15 2015-04-29 中国科学院化学研究所 Seven-element-ring polyhydroxy nitrone and preparation method and application thereof
CN111018770A (en) * 2019-12-26 2020-04-17 北京鑫开元医药科技有限公司 Preparation method of bazedoxifene oxide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3403778A1 (en) * 1984-02-03 1985-08-08 Degussa Ag, 6000 Frankfurt CYANOMETHYL- (2-CYANO-ETHYL) - (3-HYDROXY-PROPYL) -AMINE HIS USE FOR PRODUCING 1- (3-HYDROXY-PROPYL) -1,4-DIAZEPANE AND 1,4-BIS (3- (3rd , 4,5-TRIMETHOXYBENZOYLOXY) -PROPYL) -DIAZEPAN
AU686691B2 (en) * 1994-01-12 1998-02-12 F. Hoffmann-La Roche Ag Novel azepanes and homologs thereof

Also Published As

Publication number Publication date
CA2282254A1 (en) 1998-08-27
WO1998037218A1 (en) 1998-08-27
JP2001515471A (en) 2001-09-18
CA2282254C (en) 2006-03-21

Similar Documents

Publication Publication Date Title
AU8140898A (en) Inhibitors of beta-lactamases and uses therefor
PL313871A1 (en) Inhibitors of hiv protease
AU1271297A (en) Inhibitor of ceramidase
AU4135697A (en) Novel acetamide derivatives and protease inhibitors
AU6870098A (en) Indazoles of cyclic ureas useful as hiv protease inhibitors
AU5644896A (en) Protease variants and compositions
AU5493598A (en) N-hydroxy-beta-sulfonyl-propionamide derivatives and their use as inhibitors of matrix metalloproteinases
PL333505A1 (en) Benzamido-aldehydes and their application as inhibitors of cysteinic proteases
AU6897094A (en) Identification and use of protease inhibitors
AP9701054A0 (en) Inhibitors of cycteine protease
AU2243497A (en) Laser induced improvement of surfaces
PL337725A1 (en) Inhibitors of proteases
PL328665A1 (en) Inhibitors of serinic protease
AU3124300A (en) Inhibitors of beta-lactamases and uses therefor
AU7139598A (en) Protease inhibitors
AU2190400A (en) Inhibitors of beta-lactamases and uses therefor
AU4505199A (en) Methods and compositions for increasing penetration of hiv protease inhibitors
AU9374298A (en) Preparation and use of biofilm-degrading, multiple-specificit y, hydrolytic enzyme mixtures
AU6303898A (en) Component of bromelain
AU9624398A (en) Pyrrolopyrrolidine derivatives and their use as serine protease inhibitors
AUPM982594A0 (en) HIV protease inhibitors
AU9061798A (en) Protease variants and compositions
AU7518694A (en) Retroviral protease inhibitors and combinations thereof
AU6828894A (en) Hiv protease inhibitors
AU9300298A (en) Protease inhibitors